Live Breaking News & Updates on Vickil Sato

Stay updated with breaking news from Vickil sato. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Denali Therapeutics (NASDAQ:DNLI) Releases Earnings Results, Beats Estimates By $0.01 EPS

Denali Therapeutics (NASDAQ:DNLI) Releases Earnings Results, Beats Estimates By $0.01 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Vickil Sato , Goldman Sachs Group , Securities Exchange Commission , Denali Therapeutics Inc , Denali Therapeutics Company Profile , Denali Therapeutics , Get Free Report , Exchange Commission , Director Vicki , Therapeutics Inc , Denali Therapeutics Daily ,

Denali Therapeutics (NASDAQ:DNLI) Hits New 52-Week Low at $14.56

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.56 and last traded at $14.79, with a volume of 172121 shares trading hands. The stock had previously closed at $15.56. Analysts Set New Price Targets Several analysts have issued […] ....

United States , New Zealand General , New Zealand , Vickil Sato , Bryanj Watts , Denali Therapeutics Company Profile , Norges Bank , Hermes Inc , Goldman Sachs Group , Wellington Management Group , Vanguard Group Inc , Denali Therapeutics Inc , Capital Research Global Investors , Denali Therapeutics , Get Free Report , Therapeutics Trading Down , Director Vicki , Management Group , Research Global Investors , Therapeutics Inc , Denali Therapeutics Daily ,

Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) Director Sells $30,471.14 in Stock

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) Director Vicki L. Sato sold 1,666 shares of the company’s stock in a transaction on Monday, April 15th. The shares were sold at an average price of $18.29, for a total transaction of $30,471.14. Following the completion of the sale, the director now directly owns 118,043 shares […] ....

United States , Los Angeles , Vickil Sato , Financial Services Group Inc , Goldman Sachs Group , Vanguard Group Inc , Fisher Asset Management , Denali Therapeutics Inc , Los Angeles Capital Management , Denali Therapeutics , Get Free Report , Director Vicki , Therapeutics Stock Down , Angeles Capital Management , Services Group , Therapeutics Inc , Denali Therapeutics Daily , Nasdaq Dnli , Insider Trading , Nsider Trades ,